report strong result mark consist volum strong
revenu per req mix driven in-lin guidanc pama
repres multi year headwind view larg independ well
posit see patient engagement/access initi addit health
system partnership share gain like offset continu
like attract core trend pama creat challeng maintain
hold rate rais pt ep
result strong post solid result across board revenu
come roughli in-lin volum growth
acquisit augment strong revenue/req
growth driven robust benefit test mix adjust ebit
in-lin estim adjust ep two cent ahead
 robust like acceler pama continu torrid
 pace close cleveland heart lab shiel medic
laboratori deal total acquisit recent
announc acquisit medxm bolster new set asset
provid increment access mobile/hom segment expand
extend care capabl manag expect medxm
deal growth contribut exceed previou guidanc
continu expect long term revenu
compound-annual-growth-rate acquisit driven new reimburs realiti
pama see addit upsid share gain smaller medicar heavi
patient access initi take hold effort contempor patient
interact gain traction addit patient util
myquest mobil app increas access lab result half
psc live echeck-in kiosk expect roll end
reduc cleric time patient phlebotomist safeway
nr collabor also expand lab
servic avail safeway state walmart fl tx
come
guidanc despit coupl tweak report standard stock base
comp revenu recognit guidanc in-lin expect
tr target
adjust non-control interest equiti earn
jv
revenu grow consist previous disclos long term
guidanc adj ep expect rang cffo
expect capital-expenditure anticip
tax benefit reinvest business/
model review
page
flow gener remain robust cffo solidli beat
estim bad debt improv bp sequenti finish roughli flat year
end compani repurchas share quarter finish gener
origin expect run rate invigor save expect continu drive
compani continu pursu legisl solut pama repres headwind next
year impact expect given compani
size/sophist modest medicar exposur financi flexibl continu view
well posit weather pama absolut especi rel basi
page
base teterboro nj lead provid diagnost test inform
relat servic compani offer patient physician access diagnost laboratori
servic nation network region laboratori patient servic center
addit rapid respons laboratori compani also offer esoter test includ gene-
base test substanc abus test anatom patholog servic test clinic trial
clinic lab remain integr part healthcar deliveri model diagnost test
critic compon treatment decis process uncertainti around reimburs increas
applaud recent step manag drive sharehold valu reimburs bear
watch volum growth remain key
valuat risk
price target base trade cash ep slight premium
current multipl view appropri given solid underli trend strong free cash flow
gener ramp contribut profession lab servic risk rate price target
upsid includ acceler volum growth improv price potenti accret
downsid risk includ deceler volum stronger anticip reimburs headwind
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
